摘要
介入式心室辅助装置(percutaneous ventricular assist device,PVAD)作为一种微创化治疗手段,可以替代衰竭心脏的功能,为复杂冠状动脉粥样硬化性心脏病、急性心肌梗死合并心源性休克、慢性心力衰竭急性失代偿等心血管急危重症患者提供循环支持。PVAD的发展从Hemopump的崛起到Impella的繁荣,越来越多地用于血流动力学支持从而改善预后。本文将对PVAD的发展历程及临床应用进行综述。
Percutaneous ventricular assist device(PVAD)is a minimally invasive treatment which can replace the function of the failing heart.It provides circulatory support for patients with severe emergent cardiovascular diseases such as complex coronary artery disease,acute myocardial infarction complicated by cardiogenic shock,and acute decompensated chronic heart failure.PVAD has been developed since the rise of the Hemopump,to the prosperity of the Impella,and increasingly been used as a haemodynamic support to improve prognosis.This article will review the evolution and clinical application of PVAD.
作者
尚小珂
杨云骢
游辉辉
杨夏燕
孙明
吴春林
张雄
王美莹
王雪丽
陈松
张长东
柳梅
董念国
SHANG Xiaoke;YANG Yuncong;YOU Huihui;YANG Xiayan;SUN Ming;WU Chunlin;ZHANG Xiong;WANG Meiying;WANG Xueli;CHEN Song;ZHANG Changdong;LIU Mei;DONG Nianguo(Department of Cardiovascular Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430022,P.R.China;Laboratory of Department of Cardiovascular Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,430022,P.R.China)
出处
《中国胸心血管外科临床杂志》
CSCD
北大核心
2023年第12期1683-1691,共9页
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金
国家重点研发计划(2016YF0101100
2021YF1101900)。